UNIT 1: Healthcare Marketing, Digital Marketing Strategy, Social Media Strategy Publications
Welcome to my portfolio...
I am a healthcare marketing executive leader that elevates brand, product, digital, content, managed care and market access strategy success.
My background spans an array of medical specialties, products, services and technologies.
Scan the list of 14 units below then scroll down and click on the titles of examples to open them as they appear:
UNIT 1: Healthcare Marketing, Digital Marketing And Social Media Strategy
UNIT 2: Managed Care And Market Access Strategy
UNIT 3: Oncology And Cancer Treatment
UNIT 4: Amazon Care, Amazon Pharmacy - PillPack, Amazon Web Services, Amazon
UNIT 5: Healthcare Industry Innovation
UNIT 6: Healthcare Data And Clinical Technology
UNIT 7: Vaccines, Immunizations, Allergies
UNIT 8: Healthcare Industry Events And Leadership News
UNIT 9: Hospitals, Health Systems, Medical Practice Groups, Rural Healthcare
UNIT 10: Google Cloud Healthcare & Life Sciences, Verily Life Sciences, Alphabet
UNIT 11: Healthcare Business And Merger & Acquisition Strategy
UNIT 12: Healthcare Technology Case Studies, Whitepapers On RPA, EHR, EMR
UNIT 13: Digital And Print Marketing Communications (Earlier Deliverables)
UNIT 14: Bare Sky Marketing Portfolios And Blogs
UNIT 1: Healthcare Marketing, Digital Marketing Strategy, Social Media Strategy Publications
Social media is a key element of many healthcare marketing campaigns and it's important to learn how to realign brand, digital, product and service marketing strategies to account for the new opportunities and challenges in 2021
The basic elements of successful healthcare email marketing campaigns
2021 represents a year of new business challenges for the healthcare industry. Retargeting is a form of online advertising that orchestrates follow-up opportunities to engage viewers that have visited and left a website or social media venue.
7 priorities to improve healthcare website patient experience and profitability. Medical groups, hospitals, health systems and specialty practices are improving how they manage their website and digital strategy to achieve their clinical care and commercial business objectives.
Always changing, healthcare clinical and commercial terminology demands a simplistic keyword SEO content strategy
Healthcare marketers are viligently monitoring social media audience changes and preparing for 2021
Nurses, doctors and other clinicians are unique personas. Marketing to them and their leadership is challenging. Giving more thought to your landing pages has never been more important.
How To More Effectively Engage Healthcare Professionals With PPC
Digital marketing strategies spanning website, remote conferencing. PPC, email marketing, mobile and other elements take on new importance.
Successful healthcare email marketing follows its own set of rules!
Living in the digital age means we all benefit from creating and sharing information; it's even more important that we can readily understand it according to our level of health literacy...
Resourceful healthcare marketing teams are retracing steps to find and deploy under-utilized digital assets
10 elements improve your business writing and your credibility while magnifying the learning experience for your healthcare business readers
Direct-to-consumer TV ads deliver results for prescription drug and other healthcare product manufacturers Television advertising for prescription drugs is a controversial practice but is an important component of the marketing strategy for many pharmaceutical manufacturers plus other healthcare product manufacturers.
Healthcare television advertisers can improve ROI by embracing audience second-screening / two-screening habits
For many healthcare, medical device and pharmaceutical product manufacturers and service providers, the 4th quarter is underway and the end of the fiscal year is approaching. Every minute and every dollar counts more than ever.
Sometimes even the best healthcare content can't be found... Quality healthcare content requires significant time, financial and technical investment to develop. Even with solid expertise and considerable resources, the highest quality material can be seemingly ineffective as search engines and audiences stream by it.
Healthcare digital marketing initiatives need to stay ahead of the pace as patient care, technology and competitor innovation never stagnate. Even when digital assets are performing at peak levels and sales are robust, there is already room for improvement.
For healthcare industry and other marketers, it is an optimum model to revisit and compare against existing TV advertising and digital marketing activities to develop more impactful and measurable marketing initiatives with greater ROI. With dwindling broadcast television audiences and an ever-increasing selection of alternative digital and social media venues for audiences to migrate to, healthcare marketers need to develop better advertising / marketing strategies and reap more...
The top email providers are Gmail, Yahoo, Outlook, GMX, Zoho, iCloud, AOL, Elude according to MUO... While numerous digital communication and promotion options exist, email continues to be one of the most preferred channels. Despite the demise of email marketing forecast years ago, it continues to be an attractive and effective tool in engaging audiences. Its performance and utility intrigues marketers and at the same time challenges them and their audience based on sheer volume and...
Organize, Strategize, Optimize To Increase Effectiveness And Sales... Digital marketing initiatives are a mainstay in healthcare industry commercial organizations and sales generation activities. On the surface, they are aesthetically engaging and smoothly functional. Underneath, there is a wide array of organizational, financial and technical resources paddling furiously to develop and deploy them.
The most successful healthcare content marketing strategies embrace the concept of relentlessly jockeying for position when it comes to audience engagement, search ranking and ROI... Healthcare And Technology Compete Against Themselves Everyday... Healthcare content marketing is a never ending race. Healthcare and digital technology are two industries which literally outpace themselves with innovation; as quickly as existing customer / sales opportunities are accounted for, new ones evolve...
Mobilize Healthcare Marketing And Sales ROI... With much of the globe accessing the Internet for information from mobile devices, mobile marketing is a critical element to consider in effectively engaging customers and driving sales. Clinicians (nurses, doctors, pharmacists, researchers, KOLs, etc.), healthcare administrators, risk management, purchasing professionals, patients and consumers rely on mobile devices to readily access information.
Social media and other digital channels offer an array of choices to engage consumer, patient, clinician, payer and other stakeholders. There are many resources and strategies to choose from. Infographs have powerful attributes making strategic assets to improve healthcare digital marketing performance, social sharing, brand awareness and ROI. Go the distance in making it easy to share; there are countless infographs and other content featured in blogs and websites not easily shared or...
Healthcare digital marketing and social media marketing strategies are complex and inherently challenging to effectively manage. They require close alignment of significant staff, financial and technical resources to achieve maximum ROI. Upon reaching prime level of performance, the new challenge is maintaining productive results, breaking through plateaus and cultivating further growth.
Experience The Buyer’s Journey Of The Digital Healthcare Consumer… — A Combination Of Multiple Digital Venues, Social Media, Key Influencers And Personal Needs Making health plan choices is an annual buyer’s journey for many. It used to be as simple as “signing up for the company plan”. Changing trends in benefit designs (HSAs, HMOs, PPOs, FSAs, ACOs, health system-based plans, etc.) combined with consumer-driven healthcare and healthcare reform cultivated more variation. Digital resources...
Consumers, patients, clinicians, payers and other stakeholders across the healthcare industry coexist in a digital ocean of information sharing and data generation. Healthcare marketers of products and services live here as well and seek to maintain existing connections with customers and make new ones as more digital marketing options and venues emerge. Customer preferences, new digital technology and advancements in healthcare have a shared inertia healthcare marketers have to furiously...
Like Amazon, Pinterest Delivers.... It seems every company is trying to find a way to "Amazon" their sales initiatives to reach more customers, promote product, establish social media presence and provide immediate access to generate a sale. What do so many healthcare companies and their marketers overlook in their digital and social media strategies?
UNIT 2: Managed Care And Market Access Strategy
Abbott Laboratories (NYSE: ABT) has announced it is opening access to its BinaxNOW Covid-19 rapid antigen test
UnitedHealth Group weighs decision impacting its mental health and substance abuse business unit
Capital Rx’s precision pricing strategy based on accuracy and technology attracts Walmart’s attention
Centene (NYSE: CNC) continues to strategically expand with its purchase of Illinois-based NextLevel Health Partners. The deal will enable Centene to add over 54,000 Medicaid members to its ranks.
AstraZeneca's COVID-19 Vaccine Development Initiative Is Enhancing Its Global Pharmaceutical Market Access Strategy
2019 was a record year of FDA biosimilar approvals in the United States but that doesn't mean the savings they represent will be that much easier to come by
UnitedHealth Group goes on the offensive in the growing but financially and competitively challenging Medicare Advantage healthcare sector
Indian Health Services (IHS) is the federal agency providing healthcare to American Indians (AI) and Alaska Natives (AN). IHS administers mental, physical, social and spiritual health programs and services for members of recognized tribes.
The global healthcare marketplace continues to evolve. Pharmaceutical manufacturers, medical device manufacturers and healthcare service companies are driving forward to find and develop the promising opportunities that exist in emerging markets.
The healthcare partnership of Amazon, Berkshire Hathaway and JPMorgan Chase is seeking a new CEO. Haven’s present CEO, Dr. Atul Gawande, will continue as a senior leader of the Haven organization in the role of chairperson of its board of directors.
The new migraine drug Vyepti (eptinezumab-jjm) from Lundbeck (OTCMKTS: HLUYY) competes in a thickly competitive therapeutic sector where managed care contracting and market access strategy with MCOs and PBMs will be critical for it to be successful..
Anthem will buy Medicaid operations owned by WellCare Health Plans in Missouri and Nebraska as Centene offloads specific units to win approval of its WellCare acquisition by regulators.
Walgreens Boots Alliance ( NASDAQ: WBA ) ranks at number 17 on the Fortune 500 list of largest firms. Kroger, McKesson, Microsoft and Prime Therapeutics are four of Walgreens' present strategic partners.
IngenioRx - Healthcare Business Climate Changer... The recent announcement of a PBM partnership between Anthem and CVS Healthcare is a significant development. Anthem is one of the largest managed care organizations in the United States. CVS Health is a coast-to-coast healthcare conglomerate comprised of retail / mail order / specialty pharmacy, home infusion, PBM and other clinical, commercial healthcare units.
With Anthem leaving in 2019 and a new year coming up fast, what can Express Scripts do for itself and investors? Anthem says, "Goodbye"... The pharmacy benefit management (PBM), health insurance, Blue Cross Blue Shield and investment communities are awash in chatter and speculation upon hearing the news Anthem does not plan to be a client of Express Scripts effective 2019.
California, Other States Going Grizzly On Pharmaceutical Manufacturers ...According to the U.S. Census Bureau, California is the most populous state; with 39.25 million people its boundaries contain more individuals than the 21 least populous states combined... On Monday 10/9, California Governor Jerry Brown signed into law legislation requiring pharmaceutical manufacturers to report certain price hikes for prescription medicines.
Over $40 billion in annual sales... Centene is a unique managed care conglomerate based in St. Louis, Missouri which has quietly grown into an industry leader. Founded in 1984, Centene has over 30,000 employees and generates over $40 billion in annual sales.
Pharmaceutical manufacturers getting access via outcomes contracting... Health plans are increasingly seeking to feature performance guarantees in their contracts with pharmaceutical manufacturers. As drug costs rise, insurers want more bottom line certainty plan members have positive outcomes based on the therapeutic efficacy of the prescription medications they are taking.
Deductibles turn gears in consumer choice, plan design and risk management... Deductibles have become a standard healthcare benefit feature in many plans. In basic terms, a deductible is a specific dollar amount a health insurance plan requires a member to pay out-of-pocket towards medical care costs each year before the member's plan begins to pay for covered expenses.
UNIT 3: Oncology And Cancer Treatment
Jemperli (dostarlimab-gxly) is FDA approved to treat recurrent or advanced dMMR endometrial cancer
Bristol Myers Squibb and bluebird bio launch Abecma, a CAR-T therapy for multiple myeloma
FDA Issues Zynlonta (loncastuximab tesirine-lpyl) Accelerated Approval For Oncology
The U.S. Food and Drug Administration (FDA) has approved a new oncology therapy developed by G1 Therapeutics. Cosela (trilaciclib) earned an indication from the FDA to decrease the incidence of chemotherapy-induced myelosuppression in adult patients when administered before a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive-stage small cell lung cancer ( ES-SCLC).
Takeda acquires oncology innovator Maverick Therapeutics
Merck and Sanofi explore the development of an oncology tandem therapy
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) has earned FDA approval for Danyelza (naxitamab-gqgk), in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), for pediatric patients one year of age and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow demonstrating a partial response, minor response, or stable disease to prior therapy.
Breast Cancer Is A Significant Global Healthcare Challenge October is National Breast Cancer Month, a national observance in the United States that began in 1985. About 1 out of every 8 women in the U.S. (approximately 12%) will be diagnosed with breast cancer in their lifetime.
Seattle Genetics Corporate Rebrand To Seagen Mirrors Its Transformation To A Global BioPharma Leader In Oncology
Gene sequencing leader Illumina Inc. (NASDAQ: ILMN) is investing $7.1 billion in cash and stock to buy oncology diagnostics brain trust Grail Inc. in a pairing of two west coast life sciences companies. Based in San Diego, California, Illumina is a leader in the development, manufacturing and marketing of integrated systems for analysis of genetic and biological testing.
Astex Pharmaceuticals, a division of Otsuka (OTCMKTS: OTSKY) has received FDA approval for Inqovi (decitabine and cedazuridine). It is indicated for the treatment of myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML) in adult patient populations.
The FDA has approved Phesgo (pertuzumab, trastuzumab and hyaluronidase–zzxf) to treat adult patients with HER2-positive breast cancer that has spread to other parts of the body and for treatment of adult patients with early HER2-positive breast cancer.
Eli Lilly's (NYSE: LLY) Retevmo (selpercatinib) has earned FDA approval. Retevmo’s 3 FDA-approved uses provide oncologists with a triple-threat to treat more patients. Its oral formulation is a plus to avoid costly and cumbersome IV administration and the two capsule strengths provide flexibility in dosing for clinicians.
John G. Baresky AbbVie (NYSE: ABBV) is wasting no time in making the most out of 2020. Following the FDA approval of their breakthrough Women's Health uterine fibroid therapy Oriahann ((elagolix, estradiol, and norethindrone acetate capsules; elagolix capsules)) and completion of their $63 billion acquisition of Allergan, AbbVie has immediately followed through by signing deals with Genmab (NASDAQ: GMAB) and Jacobio Pharmaceuticals.
The FDA has issued approval for Lynparza (olaparib) in the treatment of adult patients with deleterious or suspected deleterious germline or somatic homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer (mCRPC) who have progressed following prior treatment with Xtandi (enzalutamide by Pfizer/Astellas) or Zytiga (abiraterone by Centocor/Johnson & Johnson).
The FDA has approved Zepzelca (PM1183) for the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.
A new multiple myeloma therapy... Sarclisa (isatuximab-irfc) is a new IV oncology product from Sanofi that is approved by the FDA for use in the treatment of adult patients with relapsed refractory multiple myeloma who have already received at least two prior therapies.
AstraZeneca and Merck Collaboration Earns FDA New Drug Approval: Koselugo (selumetinib)
Tukysa (tucatinib) Is A Tyrosine Kinase Inhibitor (TKI) of HER2 Indicated For The Treatment Of Breast Cancer
New oncology therapy Trodelvy (sacituzumab govitecan-hziy) has an indication for adult patients with metastatic triple-negative breast cancer who received at least two prior therapies for metastatic disease
Padcev (enfortumab vedotin-ejf) a first-in-class antibody-drug conjugate (ADC) and Keytruda (pembrolizumab) a monoclonal antibody (mAb) therapy have been issued FDA Breakthrough Designation for bladder oncology treatment
Oncology initiatives in Women's Healthcare have gained another valuable therapy to improve patient care and outcomes... Merck & Co.'s Keytruda and combination partner therapy Eisai's Lenvima will keep their respective marketing and sales units very busy in the upcoming months.
The U.S. Food and Drug Administration (FDA) has approved Cyramza (ramucirumab injection, 10 mg/mL solution), in combination with erlotinib for first-line treatment of patients with metastatic non-small cell lung cancer ( NSCLC) with epidermal growth factor receptor ( EGFR) exon 19 deletions or exon 21 (L858R) mutations.
Bristol Myers Squibb continues its success in oncology by earning a liver cancer indication from the FDA for its Opdiva and Yervoy mAB tandem
UNIT 4: Amazon Care, Amazon Pharmacy - PillPack, Amazon Web Services, Amazon, Inc.
Amazon Care expands its healthcare service for Amazon workers nationwide and is marketing them to other employers
Amazon, Ascension, Intermountain Healthcare join forces with 4 other healthcare enterprises to drive changes in home care for patients
Amazon is launching a new Alexa-based healthcare service called "Care Hub". It was created to help individuals care for aging family members that live apart from them.
Amazon is taking the plunge into the wearables market sector with the introduction of "Halo". It will be competing with Apple Watch, Garmin, Google Fitbit and other contenders in the fitness tracker and wearable healthcare consumer technology categories.
The nation’s largest Blue Cross Blue Shield affiliate, Anthem (NYSE: ANTM), has announced it is expanding the member support services it offers by launching a new program based on Amazon's (NASDAQ: AMZN) Alexa and Echo applications.
Amazon escalates growth and expectations of its pharmacy enterprise
Is Amazon's COVID-19 Healthcare Coalition membership the catalyst it needs to succeed in rural healthcare, hospitals and health systems?
Amazon has chosen to partner with healthcare information and technology innovator Sharecare to accelerate and improve the performances of its Alexa platform used in healthcare settings.
Amazon taking on a larger role in employee health by providing access to primary care for more of its associates through a contract with Crossover Health medical group
In 2020 Amazon and PillPack have 2 new PBMs partnerships underway, learn more about their clinical and commercial strategy here...
Amazon Care Amazon ( NASDAQ: AMZN ) has launched an employee health clinic in Seattle for corporate staff named "Amazon Care". It was introduced via website, "Amazon.Care", a venue presently accessible to outside audiences but not formally announced to the public or investors.
Amazon introduces transformational healthcare automatic speech recognition ( ASR ) application which accurately processes patient and clinician conversation plus medical and pharmacological descriptions or terminology to enrich EHR / EMR data resources
Amazon has purchased a healthcare technology startup known as "Health Navigator". Health Navigator, based in Chicago, Illinois, is a clinical healthcare technology firm founded by an emergency medicine physician, Dr. David Thompson.
Amazon and its online pharmacy unit, PillPack, have a significant challenge. On the surface, it appears to involve only a small, Iowa-based healthcare and prescription data technology company, ReMyHealth, but drastically scales up and potentially involves some of the largest retail and mail order pharmacy, MCO / PBMs and pharmacy associations in the nation - and a somewhat ambiguous organization known as Surescripts.
In a new healthcare quest, Amazon Web Services ( AWS ) unit partners with University of Pittsburgh, University of Pittsburgh Medical Center and Carnegie Mellon University Amazon is extending its reach into healthcare. Their cloud computing business unit, AWS Cloud will share its machine learning ( artificial intelligence technology ) and enormous cloud computing resources with the Pittsburgh Health Data Alliance ( PHDA ).
Amazon has demonstrated its ability to enter new markets and successfully disrupt them. Numerous retailer and other commercial sectors have felt their squeeze; even the logistics companies transporting products to consumers and businesses feel the competitive pressure.
Based on insights from management consulting leader PwC; "Amazon does have expertise that makes it a natural candidate to look for ideas that would reform the U.S. health care industry as it tries to control costs"... It is no secret Amazon has been diligently expanding its presence in the healthcare sector.
South America's largest predator, the Amazon's Black Caiman alligator can grow up to 20 feet in length and over 1,000 pounds... Healthcare distributors, medical suppliers, wholesalers, GPOs, retailers and even product manufacturers are at risk... As Amazon prepares to explore the healthcare sector for more revenue and customers, there are numerous strategies and competitive maneuvers for it to consider.
Amazon's current flows year round... It's the holiday season and shoppers are in the stores and online. Amazon is taking orders, filling orders, shipping orders. Once the season is over, they capably process returns, refunds and exchanges -all the while shipping out new orders. Amazon's is relentlessly moving forward.
UNIT 5: Healthcare Industry Innovation
Paris-based financial services and insurance giant AXA (OTCMKTS: AXAHY) has selected enterprise technology leader Microsoft (NASDAQ: MSFT) as its partner to build a full-strength telehealth program for its clients and their members. AXA is one of the largest health insurers in the world.
Global pharmaceutical giant Pfizer (NYSE: PFE) is evaluating antiviral product pipeline candidates to treat COVID-19: PF-07321332 and PF-07304814
The U.S. Food and Drug Administration (FDA) has issued Regeneron approval for its advanced cholesterol-reducing therapy Evkeeza (evinacumab-dgnb). The product is approved and indicated as an adjunct therapy to other low-density lipoprotein cholesterol (LDL-C) lowering drugs for use with treating patients diagnosed with homozygous familial hypercholesterolemia (HoFH).
Lupkynis (voclosporin) is a new therapeutic option to treat Lupus Nephritis (LN)
ViiV Healthcare, a company exclusively devoted to the HIV/AIDs marketplace, has announced the FDA has approved its latest new therapy Cabenuva (cabotegravir and rilpivirine)
FDA approves Verquvo (vericiguat), a new cardiovascular and heart drug co-developed by Merck and Bayer AG
The U.S. Food and Drug Administration (FDA) has approved Urovant Sciences' new drug Gemtesa (vibegron) for the treatment of overactive bladder ( OAB) with symptoms of urge urinary incontinence ( UUI), urgency and urinary frequency in adults.
Walgreens (NASDAQ: WBA) has signed on DoorDash as a second consumer home delivery service partner in addition to Postmates
The U.S. Food and Drug Administration (FDA) has issued BioCryst Pharmaceuticals approval for its new drug, Orladeyo (berotralstat), with an indication to prevent attacks of hereditary angioedema (HAE) in adults and pediatric patients 12 years and older.
Imcivree (setmalonotide) is indicated for patients diagnosed with obesity due to POMC, PCSK1 or LEPR genetic deficiencies
The U.S. Food and Drug Administration (FDA) has issued emergency use authorization for Lucira Health’s COVID-19 All-In-One Test Kit
Amgen, Inc. (NASDAQ: AMGN), Takeda Pharmaceuticals, Inc. (NYSE: TAK) and UCB SA (EBR: UCB) have initiated worldwide clinical trials through the COVID R&D Alliance.
FDA approves Zokinvy (lonafarnib) based on an indication to reduce the risk of death due to Hutchinson-Gilford progeria syndrome and for the treatment of certain processing-deficient progeroid laminopathies
Contract research organizations have been around for decades. They have been the go-to for pharmaceutical, medical device and other companies seeking immediate access to specialized research resources, quality control monitoring and other services. Their role in the healthcare industry and the array of capabilities they possess has multiplied many times over.
FDA issues Regeneron's novel monoclonal antibody REGEN-COV2 emergency use authorization to treat COVID-19
FDA issues emergency use authorization (EUA) for Eli Lilly's investigational monoclonal antibody therapy (mAb) bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients
Regeneron's Inmazeb, a monoclonal antibody trifecta, takes on the Ebola virus
Veklury (remdesivir) Approved By The FDA
Roche and Atea Pharmaceuticals join forces to accelerate the development of an oral antiviral COVID-19 drug
Cue Health COVID-19 diagnostic test produces accurate results in 20 minutes and does no require laboratory resources.
Regeneron (NASDAQ: REGN) is excited about the promising clinical trial research results it is achieving with its COVID-19 antibody treatment candidate REGN-COV2. They are having conversations with the U.S. Food and Drug Administration (FDA) about receiving Emergency Use Authorization (EUA) clearance for REGN-COV2 to accelerate the product's availability to the marketplace.
Oriahnn is a first-in-class pharmaceutical therapy regimen indicated for the management of heavy menstrual bleeding associated with uterine fibroids; it was developed through a collaboration between AbbVie and Neurocrine Biosciences
Avid Radiopharmaceuticals, a business unit of Eli Lilly (NYSE: LLY ), has received FDA approval for its Tauvid (flortaucipir F18) therapy used in the imaging of a distinctive brain characteristic associated with Alzheimer’s disease referred to as tau pathology.
Kenilworth, New Jersey-based Merck (NYSE: MRK) has launched a 3-prong business initiative to combat COVID-19 and once again demonstrate its clinical and competitive mettle in global healthcare. Their strategy is centered on spearheading the development of two vaccines and one antiviral agent.
The FDA has approved Artesunate for injection as an antimalarial therapy indicated for the initial treatment of severe malaria in adult and pediatric patients.
Medical waste companies are pivotally important in the quest to overcome the global challenge of COVID-19
Texas-based Pulmotect Gets FDA Greenlight For Phase II Clinical Trial of PUL-042 - A Nebulizer Administered Inhaled Therapeutic Agent To Treat COVID-19 Patients
Supplemental application to treat hepatitis C approved by FDA... Epclusa (sofosbuvir and velpatasvir), in combination with ribavirin, has been issued a supplemental approval to be used in children ages 6 years and older or weighing at least 37 pounds (17 kilograms) diagnosed with any of the six Hepatitis C virus (HCV) genotypes - or strains - without cirrhosis (liver disease) or with mild cirrhosis.
For over 100 Walgreens has built its esteemed pharmacy empire on strategic innovation. As it rolls into a new decade, it has already introduced a new chief medical officer, Dr. Kevin Ban, a new president, Richard Ashworth, and is now expanding delivery service from 2 metropolitan areas into an additional 13.
Roche has communicated its diagnostics business unit is accelerating the production of its Elecsys Anti-SARS-CoV-2 antibody test to come to the aid of U.S. and world markets. The company has shared the news that the U.S. Food and Drug Administration (FDA) has issued it an Emergency Use Authorization (EUA) for the diagnostic product.
New Multiple Sclerosis Drug Zeposia (ozanimod) FDA Approval Adds To Bristol Myers Squibb's Success In 2020
FDA Revising 2008 Type 2 Diabetes Industry Guidance
The FDA has issued 510(k) clearance for Baxter's new generation of Peri-Strips Dry with Veritas collagen matrix (PSDV) staple-line reinforcement material products that feature peel-and-secure technology.
Horizon Therapeutics (NASDAQ: HZNP) has received approval for its thyroid eye disease Tepezza (teprotumumab-trbw) pharmaceutical product. Thyroid eye disease (TED) is a healthcare condition centered on inflammation of the eyes, eye muscles, eyelids, tear glands and fatty tissues behind the eye. TED, also known as Graves' Orbitopathy or Ophthalmopathy, is an autoimmune condition.
Nexletol is an add-on cholesterol lowering treatment for use with patients prescribed statins
FDA Issues Direct Warnings And Takes Further Action Against Retailers and Manufacturers Of Unauthorized E-Cigarette Products
15 Important Facts About Johnson & Johnson
CDC has defined vaping-related illnesses as “EVALI” –an abbreviation for “e-cigarette, or vaping, product use associated lung injury”. As the issues surrounding the use and healthcare consequences of e-cigarettes and vaping continue, medical professionals, the Centers for Disease Control and the FDA are dialing in quickly while engaging multiple related concerns.
With diabetes as a growing healthcare issue around the globe, medical professionals benefit from having more advanced treatment options to prescribe their patients... With the FDA's approval, Novo Nordisk has announced they are launching a new oral therapy for diabetes care. Expectations are the new product named "Rybelsus" will generate over $5 billion in sales by 2026.
Biosimilar Warfare... Merck & Co and partner Samsung Bioepis have introduced their biosimilar version of Johnson & Johnson's Remicade in the United States healthcare marketplace. They are not shy in their intent to make a name in the biosimilar sector for themselves.
A recently released BCBS report focused on diabetes care further defines the reach and associated issues of diabetes; its results were especially concerning as it confirms a higher prevalence of the disease in a younger population segment... Blue Cross Blue Shield Health Index...
United HealthCare continues the trend... Take a close look at the picture. It is the first hospital in the United States. Known as "Pennsylvania Hospital", it was founded on May 11, 1751 by Benjamin Franklin and Dr. Thomas Bond. It is located in Philadelphia, Pennsylvania and is on the National Register of Historic Places.
Digitalization, Consolidation, Private Equity, Business Model Hybridization, Audience Migration, Amazon, Google, Apple 2018 promises to be an eventful year across multiple healthcare sectors based on 2017's high performance direction. While healthcare has never been an industry to hover from year to year, there will be an array of significant changes impacting clinician, commercial and consumer / patient interests.
UNIT 6: Healthcare Data And Clinical Technology
Truveta is a new organization founded by hospitals and health systems focused on discovering and applying healthcare data insights to optimize patient outcomes
The U.S. Department of Veterans Affairs (VA) and Apple are partnering to provide better care for veterans nationwide. The two organizations have launched a telehealth program centered around the distribution and use of iPads.
Healthcare provider organizations are developing flexible and profitable telehealth strategies for 2021
NightWare, Inc. develops Apple Watch and Apple iPhone solution to help patients with sleep disorders triggered by PTSD
The company has announced its new Microsoft Cloud dedicated to healthcare will be available on 10/30/20. Microsoft introduced the development of this new initiative in May and is now positioned to benefit an array of eager medical professionals, healthcare provider organizations, partners and investors.
Series 6 Apple Watch reads blood oxygen levels and Fitness+ workout videos will feature new editions weekly
Virtual Health Assistants Embraced by Patients, Medical Professionals and Healthcare Provider Organizations
Traditional In-Person Counseling And Virtual Counseling Business Models Competing For Patients And Revenue
University of Pittsburgh Medical Center (UPMC) and its Enterprises unit are deploying $1 billion for life sciences investments; UPMC continues to advance patient care as a global healthcare leader
The FDA has unveiled its new Digital Health Center of Excellence as a major enhancement to its ability to support the use of technology in patient care. The new agency unit will operate within the Center for Devices and Radiological Health (CDRH) located in Silver Spring, Maryland.
UnitedHealth Group (UHG) and Microsoft Corp. are developing and launching a "back-to-workplace" healthcare initiative called ProtectWell. It's a formal plan and technology-driven solution for employers and their staff members.
IBM Takes Leadership Role With Washington In COVID-19 Supercomputing Initiative
Artificial Intelligence (AI) is at the center of Microsoft's new AI for Good healthcare program
Proposed changes to the 21st Century Cures Act include making electronic health record (EHR) data and other healthcare information accessible to patients/consumers via mobile technology. Why is Epic Systems against it? Numerous benefits include health literacy and personal patient care knowledge while privacy, security and costs are important considerations.
Microsoft and Google are both investors in DNAnexus, a high profile precision medicine start-up... DNAnexus is a leader in biomedical informatics and data management. Its latest round of funding totaled approximately $58 million. DNAnexus, which has developed a cloud-based platform for biomedical informatics and data management, will apply the monies towards precision medicine and genomic data management solutions for clinical trials.
Telemedicine Here To Stay... Healthcare has always been an industry synonymous with change. How it is paid for, who provides it, procedures performed, medicines prescribed are touchpoints which are top-of-mind when it comes to healthcare industry changes. Telemedicine and how / where healthcare is provided is increasingly becoming a mainstay topic.
UNIT: 7 Vaccines, Immunizations, Allergies
CanSino Biologics Commits To Yearly 500 Million Single-Dose COVID-19 Vaccine Production Goal
Johnson & Johnson escalating COVID-19 vaccine production with support from Merck and BARDA
Sinopharm accelerates global market access strategy with new 3 billion dose COVID-19 vaccine annual production quota
The FDA has issued emergency use authorization for Pfizer’s (NYSE: PFE) and BioNTech’s (NASDAQ: BNTX) coronavirus vaccine.
Nestle covets Aimmune's novel Palforzia therapy that is FDA-approved to treat peanut allergies
CVS Health and Walgreens Chosen By Health and Human Services (HHS) For National Coronavirus Vaccine Program
Ebola persists as a threat in Africa despite widespread vigilance and responsive containment measures
Preparation for the 2020-2021 flu season is underway even as we continue to grapple with the immediate threat of COVID-19. The upcoming flu season will be even more strategically regarded than in years past and the anticipated demand for flu immunizations greater.
Palforzia (arachis hypogaea) is a new drug approved by the FDA for patients allergic to peanuts.
Moderna is deploying its mRNA expertise to immunization development... Washington has signed on another biotech firm to help find a vaccine solution to COVID-19. Moderna and the Biomedical Advanced Research and Development Authority ( BARDA) have entered into an agreement to accelerate the development of an immunization for COVID-19.
Audenz (Influenza A (H5N1) Monovalent Vaccine, Adjuvanted), developed by Seqirus, has been approved by the FDA. The product is indicated for use in persons 6 months of age and older at increased risk of exposure to the influenza A virus H5N1 subtype contained in the vaccine.
Let's hope other governments and companies step up to the plate with similar or greater commitments to developing COVID-19 solutions
WHO has issued PHEIC status only 5 times before... The World Health Organization has declared the Coronoavirus 2019-nCoV a Public Health Emergency of International Concern ( PHEIC). The declaration of PHEIC is rare. Upon its designation, various government agencies, healthcare institutions and other stakeholders are officially organized to act and escalate measures in collaboration with each other to combat the issue.
The Centers for Disease Control ( CDC ) plus other government healthcare agencies and medical professionals are closely monitoring what is shaping up to be a formidable Flu season. Who is most at risk for Flu? Individuals spanning infant to elderly are susceptible to the Flu virus.
Merck ( NYSE: MRK ) has announced its Ebola vaccine, Ervebo, has been approved by European regulators. The product, which has already been deployed in its investigational format in the Democratic Republic of Congo ( DRC ), was cleared by Europe's "Committee For Medicinal Products for Human Use ( CHMP )" and will be manufactured in Germany.
Clinicians and government health agencies are concerned. Fall is the threshold to the Flu season and the emergence of Measles earlier in the year is a continuing issue.
Public health experts center on false content online as playing a significant role in scaring parents away from getting their children vaccinated... Facebook and Instagram will direct users searching for Measles immunization information and other types of vaccine details to the World Health Organization ( WHO ) for credible facts.
Options to immunize against HPV... Gardasil, Gardasil 9 and Cervarix: your table is ready. Each of these products is FDA-approved to prevent HPV infection; Gardasil is a Merck product, Cervarix is produced by GlaxoSmithKline. They are all effective against HPV types 16 and 18, the two high-risk HPVs which cause about 70% of cervical cancers and a greater percentage of some of the other HPV-associated cancers.
UNIT 8: Healthcare Industry Events And Leadership Profiles
The CDC and EPA recognize May as National Asthma Awareness Month
National Pediatric Transplant Week focuses on saving the lives of those persons just starting out in life. - Organ transplant medical professionals need more persons to register as organ donors so they can save more lives.
Her Leadership And Sacrifice: Dr. Adeline Marie Fagan - Learn her story and follow her example
UHC, the nation's largest health insurer, has a new CEO: Brian Thompson
Global pharmaceutical giant Merck (NYSE: MRK) has named Robert Davis as their next chief executive officer. Davis joined Merck as a chief financial officer in 2014. .
An executive profile of Walgreens' new CEO Rosalind Brewer, presently the only black woman Fortune 500 CEO
National Organ Donation Day Is Sunday, February 14th, 2021 --organ donors save lives; register now to become an organ donor! The Health Resources & Services Administration (HRSA) designates Sunday 2/14/ 21 as National Donor Day. National Donor Day recognizes persons in need of an organ transplant, organ donors and urges more people to register to become organ donors.
Health & wellness and corporate social responsibility continue as key elements in Starbucks' 2020 business strategy
Women are making history and creating the future of healthcare in the United States
National Nurses Day was launched on May 6, 1982 by the American Nursing Association (ANA) - National Nurses Week Begins On May 6 And Ends On May 12 -Florence Nightingale's Birthday
National Nurses Day on May 6th kicked off National Nurses Week. Its closing day, May 12th, is International Nurses Day that is also dedicated to the founder of modern nursing practice, Florence Nightingale, who was born on May 12th, 1820.
Friday, February 14th is National Donor Day --Donor as in Organ Donation - Over 120,000 persons in the United States are in need of an organ transplant. For many of them, their life depends on it. Almost 40,000 organ transplants were conducted in 2019, setting another record for this medical procedure.
Dr. Arnold Menezes, MBBS, University of Iowa professor and vice-chairperson of the Department of Neurosurgery, earns 2019 Franc D. Ingraham Award for Distinguished Service and Achievement. It is the highest honor issued by the American Association of Neurological Surgeons and Congress of Neurological Surgeons Section on Pediatric Neurological Surgery
Bristol Myers Squibb (BMS) is fortifying its senior leadership with the addition of Elizabeth Mily as Executive Vice President, Strategy & Business Development. According to information shared by BMS (NYSE: BMY), Elizabeth will lead strategy and all business development activities such as strategic partnerships, mergers & acquisitions and other important initiatives.
Deerfield, Illinois-based Walgreens Boots Alliance (NASDAQ: WBA) has selected John Standley as president of Walgreens. Standley will be responsible for all of the pharmacy giant's store operations in the United States.
February is fast approaching and chocolate is a Valentine's Day staple. Over 55 million pounds of chocolate are sold during the week leading up to Valentine's day. Chocolate is not an essential food group nor an essential vitamin but its popularity deserves attention on any given day.
Walgreens signs Dr. Kevin Ban, MD, as new Chief Medical Officer
The Association of American Medical Colleges ( AAMC ) reports that based on its data, more females than males are enrolled as medical students throughout the nation. Medical school applicants and medical school enrollees are transforming the future of physician ranks.
The CEO with a 20 year track record of clinical and commercial success is stepping down. A strategic succession of executive leadership at Abbott is underway. After 21 years as CEO, legendary pharmaceutical, diagnostic and medical device merger & acquisition strategist and corporate leader Miles White is handing over the CEO reins of Abbott to his planned successor, Robert Ford, Chief Operating Officer and President of Abbott, Inc.
In an era of wellness, healthcare costs, tobacco avoidance and pharmaceutical medical device regulation; how did e-cigarettes and vaping products avoid more medical scrutiny until now? JUUL CEO resigns... Kevin Burns has resigned as Juul's CEO. Burns will be replaced by former Altria executive K.C. Crosthwaite.
UNIT 9: Hospitals, Health Systems, Medical Practice Groups, Rural Healthcare
A leading Chicago area community health system, Palos Health, merges with Northwestern Medicine
The USDA has announced it is funding 86 projects through the Distance Learning and Telemedicine (DLT) grant program. It helps rural healthcare organizations and rural educators improve their connections with and better support their patients or students. The new flow of monies is largely attributed to the demands and issues triggered by the COVID-19 pandemic.
Cherokee Nation advances medical academics and the future of patient care with new medical school
NorthShore University HealthSystem has formally completed its acquisition of Northwest Community Healthcare
Tenet Healthcare Corp. (NYSE: THC) is closing out 2020 with a strategic $1.1 billion acquisition of up to 45 ambulatory surgery centers from SurgCenter Development (SCD).
The Biden-Harris Plan To Build Back Better In Rural America promises $20 billion for rural broadband improvements -they need to honor their commitment
UPMC is selling their home infusion and specialty pharmacy company, Chartwell, to CarePathRx for about $400 million. As part of the deal, it is also committed to being a strategic investor in CarePathRx which is private equity owned.
The Department of Health and Human Services (HHS) follows through on an executive order issued by President Trump with the introduction of the Rural Action Plan
North Carolina Physician Earns Prestigious Award from the National Rural Health Association (NRHA). Dr. Jeffrey Viar has been named Rural Health Practioner of the Year.
One of the nation’s largest rehabilitation health networks, Encompass Health (NYSE: ECH), and The University of Iowa Health Care Hospital & Clinics have launched a collaboration through the opening of a new facility they will jointly operate. The venture is centered around its new inpatient rehabilitation center, the University of Iowa Health Network Rehabilitation Hospital.
Two leading health systems, Intermountain Healthcare and Sanford Health, are joining forces
The Health Resources & Services Administration (HRSA) has designated 11/15-2/21 National Rural Healthcare Week. It focuses on the leadership, innovation and challenges that rural medical professionals and their healthcare provider organizations embrace everyday to fulfill their care mission. A pivotal day of focus is Thursday, 11/19 which is designated as National Rural Health Day.
Two medical groups largely focused in urology and associated patient care have joined together with the support of private equity and formed what is likely the largest urology patient care healthcare provider organizations in the United States.
Steward Health Care Undergoes Transformation To A Physician-Owned Health System Business Model After Transitioning From Private Equity
VillageMD and Walgreens Boots Alliance Join Forces In A Robust Primary Care And Pharmacy Services Partnership
Access to care in rural areas is a national healthcare issue that cannot heal on its own... Between January 2010 and January 2020, 114 rural hospitals closed. More than 30 of these were critical access facilities. The University of North Carolina Cecil G. Sheps Center for Research provides further insights as to the total number of rural hospitals closed since 2005 total 170.
One of the largest fertility medical practice organizations in the United States, Shady Grove Fertility, has partnered with the healthcare private equity firm Amulet Capital Partners LP to develop and launch a business solutions platform to support the advanced and unique needs of fertility practices.
Rush University Medical Center Designated As Pancreatic Cancer Center of Excellence
Physician practices and medical groups of all sizes are bearing the growing burden of clinical, administrative, financial and technical risk to continue to operate. What kind of opportunity emerges for private equity interests in this challenging environment?
St. Catherine Hospital, East Chicago, Indiana is starting the new decade with a new oncology treatment center; a prime example of how to improve access to care
Johns Hopkins University is leading a unique, FDA-approved clinical trial to explore the effectiveness of blood plasma therapy in treating COVID-19 patients.
Fueled by healthcare private equity, two projects valued at $30 million each reflect national trends as medical practice group business models change
To maintain healthy populations, community residents need access to quality care. Four Chicago hospitals located in the city's southside area are forming a health system to improve care and generate economic opportunity.
A prominent Chicago area orthopedic medical group has recently grown substantially larger. Illinois Bone & Joint Institute (IBJI) has announced another leading orthopedic medical group, Hinsdale Orthopaedics, is joining its group. The combined organizations will have over 25 locations including 4 with MRI centers plus approximately 150 physicians providing an array of advanced orthopedic patient care.
Select Rehabilitation, a leader in senior care and other specialized patient care services, is buying Kindred Healthcare's RehabCare business unit.
NorthShore University HealthSystems adds the 5th hospital to its organization with the acquisition of Swedish Hospital in Chicago
There is a shortage of physicians across the United States but Illinois Bone and Joint Institute, based in the Chicago suburb of Des Plaines, Illinois has no issues with attracting top surgical talent in one of the largest and most competitive healthcare marketplaces in the nation.
According to Kaufman Hall, a Skokie, Illinois based management consulting firm with a long-established healthcare business practice, the number of hospital mergers and acquisitions in 2017 is on track to exceed the number of deals reported in 2016... Chicago's health system environment undergoing more drastic change...
A survey from Deloitte and the Healthcare Finance Management Association of 90 hospital financial executives from merged or acquired organizations and phone interviews with 13 healthcare leaders indicates hospitals and health systems are looking to mergers and acquisitions for financial, operational, and strategic value... Consolidation, Mergers, Acquisitions...
Largest Private For-Profit Health System In The United States... At the close of September, 2017, Steward Health Care announced it had completed another hospital / health system acquisition and this one has particular significance. Its buyout of IASIS Healthcare now makes it the largest private for-profit health system in the United States.
Ascension And Providence St. Joseph Health forming mega-merger... In mid-December, 2017; two major hospital systems were in merger discussions which would create a new leader in U.S. hospital ownership totaling 191 hospitals. Non-profit Ascension, based in St. Louis, Missouri and non-profit Providence St.
UNIT 10: Google Cloud for Healthcare & Life Sciences, Verily Life Sciences, Alphabet (NASDAQ: GOOGL)
Highmark Health Blue Cross Blue Shield hires Verily Life Sciences for Living Health Platform Development
Google Health, a business unit of Alphabet (NASDAQ: GOOGL), introduces the new Nest Hub with its innovative Sleep Sensing program
Verily hires a new chief information officer and a new chief marketing officer
Google Cloud's new initiative reflects its competitive focus in the healthcare sector
Verily Life Sciences' finances are recharged for 2021. As an independent subsidiary of Alphabet Verily has a unique ability to seek outside and internal sources of cash to invest in its business. Based on this arrangement it recently launched a round of funding that netted it $700 million from its parent company and other investors
Verily Introduces A Novel Strategy As It Enters The Health Insurance Industry
Verily Life Sciences announces Study Watch gets FDA-nod for irregular pulse monitoring with 510(k) designation
Google has pleasantly surprised us early in 2020 with an incredibly useful resource which will be greatly appreciated by users of healthcare data. Just recently Google announced Google Dataset Search has officially graduated from beta for users to explore and benefit from!
Alphabet ( NASAQ: GOOGL ) announced its Verily Life Sciences business unit is collaborating with California Veterans Affairs VA Palo Alto Healthcare System and Atrius Health, a nonprofit health-care organization based in Auburndale, Massachusetts. Each initiative is centered on data-driven Population Health initiatives.
Alphabet / Google on healthcare mission Dr. Karen B. DeSalvo, currently a professor at the Dell Medical School, University of Texas in Austin, will be the first person to have the title of Chief Health Officer for Alphabet / Google.
Alphabet is fortifying its healthcare and technology ranks with an experienced medical, academic and regulatory leader to oversee strategy for two of the company's health divisions: Google Health Verily Life Sciences Introducing Dr. Robert F. Califf The Forge health data science center at Duke University communicated the news about Dr. Califf via its blog.
What may Alphabet potentially gain or lose by acquiring Fitbit? It has been reported Google parent company Alphabet ( NASDAQ: GOOGL ) is seeking to acquire wearable activity tracker Fitbit. Read about the gains, precautions and goals then make your own assessment...
Google's analytic, deep thinking attributes make it ideally suited for the clinical, financial and technical challenges of the healthcare industry. The variety of Google’s deployment in healthcare demonstrates they are willing to invest in learning more about it, greatly improve something that already exists or develop something entirely new and better — which will be unsettling to competitors that have not been innovative.
Google is building its healthcare technology presence... Early in August, 2017, Google acquired Senosis Health; a highly specialized app / smartphone technology company which focuses on healthcare-related uses. Financial terms of the buy are presently not known.
Google On The Move In Oncology... Google is deploying its artificial intelligence capabilities and data analytic resources in the fight against breast cancer. Through using the artificial intelligence ( AI ) concept known as "Deep Learning", Google has been applying its super powers to diagnose cancer cells. Google, Healthcare Academics, Artificial Intelligence, Research...
UNIT 11: Healthcare Business and Merger & Acquisition Strategy
Becton Dickinson forming a new company by divesting its diabetes care business unit
Thermo Fisher Scientific resets contract research organization sector with PPD acquisition
Grand Rounds and Doctor On Demand team up to stay on top of global telehealth expansion
Microsoft and Nuance join forces in $19.7 billion deal to expand healthcare enterprise
Telehealth frontrunner MDLive bought by Cigna health services subsidiary Evernorth
Merck accelerates its advanced autoimmune therapy development strategy
Horizon Therapeutics escalates growth as a leader in advanced rare disease therapies with the buyout of Viela Bio
Thermo Fisher Scientific kicks off 2021 with 2 deals in less than a week
Walgreens Boots Alliance (NASDAQ: WBA) is selling a majority stake of Alliance Healthcare to AmerisourceBergen for $6.275 billion in cash and two million shares of AmerisourceBergen common stock.
Centene starts 2021 with a $2.2 billion deal to buy Magellan Health
3rd acquisition by Eli Lilly in 2020; Prevail Therapeutics deal accelerates its progress to expand pipeline and market sector presence
2020 continues to be a year of clinical and commercial innovation and transformation at Merck with its acquisition of OncoImmune
Novo Nordisk covets the oral drug formulation capabilities of Emipshere Technologies
Merck (NYSE: MRK) has announced it is acquiring the oncology research company VelosBio Inc. from Pappas Capital plus other investor stakeholders for about $2.75 billion. VelosBio is based in San Diego, California and was founded in 2017.
Bayer builds up its gene therapy enterprise with $4 billion Ask Bio acquisition
Bristol-Myers Squibb expanding cardiovascular product line with $13 billion MyoKardia acquisition
UHC (NYSE: UNH) is expanding its pharmacy benefit management services with its acquisition of divvyDOSE. divvyDOSE, founded in 2015, is based in Moline, Illinois.
Momenta acquisition fuels Johnson & Johnson's expansion in autoimmune therapy
Molina Healthcare acquires Affinity Health Plan of New York
Merck announces major spinoff to form a new, publicly-traded company by 2021. Merck generates over $42 billion in annual sales and is one of the world's largest pharmaceutical companies.
AbbVie Annual Sales Expected To Surpass $50 Billion In 2020 AbbVie (NYSE: ABBV) has announced that it has received final clearance from regulators and has completed its $63 billion acquisition of Allergan (NYSE: AGN). Based in North Chicago, Illinois, AbbVie is a global healthcare leader that generated over $33.5 billion in 2019 annual sales. Based in Dublin, Ireland with a U.S. headquarters in Irvine, California, Allergan produced over $16 billion in annual sales during 2019.
Molina Healthcare Expands Medicaid and Medicare Business with Magellan Complete Care acquisition
Thermo Fisher Scientific advances further into genetic testing... Thermo Fisher Scientific (TFS) moves deeper into the genetic testing market sector with its purchase of Qiagen. Qiagen (NYSE: QGEN) specializes in sample and assay technologies used in academic and pharmaceutical research, applied testing, molecular diagnostics, oncology plus other clinical and scientific applications.
With a market cap of $38 billion, the combination of Teladoc and Livongo are formidable telehealth enterprise
AmerisourceBergen acquired compounding pharmacy PharMEDium for about $2.6 billion in 2015; it is now closing the business unit due to higher operating costs, regulatory standards, quality requirements
Alexion Pharmaceuticals (NASDAQ: ALXN) has announced it is acquiring Portola Pharmaceuticals (NASDAQ: PTLA) for $1.41 billion in cash. Founded in 2003, Portola is based in South San Francisco and produces about $116 million in annual sales.
Telehealth continues to build momentum in the United States and the nation's largest commercial payer UnitedHealth Group's ( United Healthcare, Optum ) acquisition of Vivify Health exemplifies this trend.
Merck Sells The StayWell Company to WebMD/Internet Brands, a KKR private equity holding
Coveting global market potential of LDL agent "Inclisiran" Novartis announces it is acquiring The Medicines Company for $9.7 billion
Audentes Therapeutics acquired by Astellas in $3 billion deal; Astellas fully commits to gene therapy
Stryker Corporation ( NYSE: SYK ) is acquiring medical product manufacturer Wright Medical for $4 billion. Wright Medical ( NASDAQ: WMGI ) was started in 1950; it manufactures an array of products aligned with orthopedics including fixation and fusion systems designed for ankles, elbows, shoulders, toes and wrists.
In an unexpected move, Rite Aid (NYSE: RAD) has announced it is acquiring the privately-held, family-owned and operated Bartell Drugs retail pharmacy chain for $95 million.
Global healthcare leader Sanofi S.A. ( NASDAQ: SNY ) is reportedly weighing options to make significant changes to its commercial organization by spinning off its consumer healthcare products unit or aligning it with a joint-venture partner to reduce $28 billion debt load
Pharmaceutical and biotech companies are under heavy pressure to perfomr commercially for investors and clinically by healthcare customers. As they seek to build profitability and their pipelines, mergers and acquisitions are part of their corporate strategies.
Could Walgreens be strategically signaling it is up for sale to the highest bidder by presumably going through the motions of taking itself off the market through a private equity deal? Reportedly Walgreens ( NASDAQ: WBA ) is exploring options to take itself private.
UCB announces deal to buy Ra Pharma for $2.1 billion to expand rare disease pipeline
The healthcare industry continues to evolve; business models within the sector are changing and propelled by large scale merger and acquisition initiatives... The proposed CVS Health / Aetna deal combines two healthcare industry leaders with wide and deep reach across commercial and consumer business sectors nationwide.
Under The Radar Of Most Healthcare Executives... On Wednesday, 8/2/2017, PharMerica was acquired by private equity firm KKR (Kohlberg Kravis Roberts). KKR paid $1.4 billion for PharMerica. Headquartered in Louisville, Kentucky, PharMerica is a leader in pharmacy services for assisted living facilities (ALF), hospitals, long term care facilities (LTC), skilled nursing facilities (SNF) and other specialty pharmacy service sectors.
Bain Capital and Cinven... Private equity (PE) continues to be a force in changing the face of the global healthcare industry. STADA, a prominent generic drug manufacturer based in Germany, was taken private last week (8/18/2017) in a $6.3 billion dollar deal. Bain Capital and Cinven were the buyers.
Johnson & Johnson's $30 billion takeover of Swiss pharma firm Actelion...Gilead's $12 billion acquisition of Kite Pharma...Abbott finalizes Alere deal for $5.3 billion...Reckitt Benckiser Group acquires Mead Johnson Nutrition for $17.9 billion...Cardinal Health acquires Medtronic business unit for $6.1 billion...Teleflex buys Vascular Solutions for $1 billion...Hologic acquires Cynosure for $1.7 billion...Stryker purchases Novadaq for $700 million...Integra Lifesciences buys J&J's Codman...
A 2.3 Billion Dollar Acquisition Has Nationwide Impact: United Healthcare's purchase of Surgical Care Affiliates is re-writing the healthcare industry's playbook.
UNIT 12: Healthcare Technology Case Studies, Whitepapers On RPA, EHR, EMR (Drafts)
Healthcare purchasing and inventory management are complex processes that impact the patient care and financial performance of hospitals and health systems, digitization technology can maximize their performance
Medical professionals and risk management executives rely on accurate data to develop, launch and manage effective population health programs for patients
Healthcare revenue cycle management follows a complex process that need a high level of production, accuracy and control
Ongoing threats to healthcare data security and HIPPA/PHI privacy require digitally automated measures to assure compliance and protection
A health system with over 30 hospitals economically and accurately completes its new EHR implementation by digitally fortifying it with 5 million patient records
A health system improves support for its surgical teams and improving patient care through prioritizing surgical card preference card data in their new EHR system
Hospitals and health systems deploy a variety of strategies to reduce cost and improve data resource performance following mergers and acquisitions
An enterprising health system fully enhanced their new EHR system by fortifying it with complete patient clinical documentation files to better support medical staff and improve patient care
A future-focused healthcare system strategically accounts for Problem List data in their new EHR system
A major urban health system deploys 3 strategies to optimize their payer reimbursement data management processes to improve productivity and accuracy while reducing costs
Assembling the right team of administrative, medical, technical and training staff to orchestrate your new EHR implementation is a pivotal exercise
A hospital successfully integrates it medication and pharmacy data to improve patient safety and reduce data burden on medical and administrative staff
Health systems, hospitals and medical groups are reducing costs and data burden by replacing old and under-performing EHR/EMR systems
A growing health system with 150 hospitals prioritized its Emergency Department EHR data for optimization to improve patient care, reduce costs and eliminate data burden on medical professionals and administrative staff
Hospitals and health systems are improving profitability and productivity through digitizing revenue cycle management
A 15-hospital health system boosts profitably and productivity through optimizing its pricing and materials management data workflows
A leading health system optimizes laboratory and pathology data workflow
Reducing payer claim denials streamlines reimbursement and optimizes hospital and health system finances
Base presentation content
UNIT 13: Miscellaneous Print & Digital - Pharma, Device, HEOR Marketing Communications
Oncology Injectables, Infusion Technology, Disposables
Anesthesia, Pain Management And Antibiotic Injectables; Infusion Technology, Disposables
Home Infusion Injectable Therapies, Infusion Technology, Disposables
MORPHINE Addition To iSecure Portfolio (HYDROMORPHONE, KETOROLAC, MIDAZOLAM, ONDANSETRON)
FENTANYL Available In 3 Formats And 5 Strengths: 100 mcg, 250 mcg, 500 mcg, 1,000 mcg, 2,500 mcg
SUCCINYLCHOLINE QUELICIN NEUROMUSCULAR BLOCKER 200 mg VIAL
LUPRON DEPOT-GYN injection For Women's Healthcare / Endometriosis HEOR Milliman Actuarial Payer Analysis
LUPRON DEPOT-GYN injection For Women's Healthcare / Endometriosis - Hospitals, Health Systems, Government, Employers, MCOs, PBMs,
Product access and reimbursement support for health systems and medical practices; TAP Pharmacy Solutions Partnership with CVS / Caremark and Express Scripts
Prevacid Capsule, Prevacid SoluTab, Prevacid Suspension Formulations
LUPRON DEPOT-PED injection for Central Precocious Puberty / CPP
Lupron Depot-URO injection for Palliative Treatment Of Advanced Prostate Cancer
Clinical Prior Authorization, Step Care, Plan Prior Authorization Prescription Benefit Plan Services
Pharmacy Benefit Management Prescription Benefit Patient Program
Retrospective Medical And Pharmacy Care Data Analytics Clinical Program
How will healthcare reform impact Medicare?
A discussion covering the basics of Medicare
A discussion about prescription drug coverage and healthcare reform
Unit 14: Bare Sky Marketing portfolios and blogs
A selection of Bare Sky Marketing healthcare content writing examples plus professional biography, candid responses to Muck Rack's interview questions, Bare Sky Marketing Twitter posts, links to Bare Sky Marketing resources
Select Bare Sky Marketing Healthcare Content Writing Examples And Healthcare Marketing Resources
Authentic, fact-based healthcare content writing services for medical, business, investor, payer, academic, patient and consumer audiences
Marketing strategy for pharmaceutical, medical device & technology, patient care, clinical service, medical software and other healthcare enterprises
Healthcare industry insights on events, trends and innovation